Itraconazole Therapy In Bronchiectasis With Airway Mold

Summary

The primary objective of this study is to evaluate the feasibility of itraconazole therapy in patients with bronchiectasis and airway mold. Feasibility will be assessed through recruitment success, treatment adherence, tolerability, and participant retention. The study will also explore the impact on respiratory symptoms and airway microbiome diversity.

Timeline

Start

2026-06-20

Primary completion

2030-12-31

Completion

2030-12-31

Drugs

Indications